Experiment name | Clinical attributes |
Armstrong01_ALL_11 | Acute lymphocytic leukemia (Leukemia), B cells (Leukemia), Bone marrow (Leukemia), Lymphocytes (Leukemia), Acute leukemia (Leukemia*), Hematologic cancer (Leukemia*), Cancer (Leukemia*), Leukemia (Leukemia*), Monocytes (Leukemia*), Hematologic samples and cell lines (Leukemia*), Hematologic cancer and cell line (Leukemia*), Cancer and cell line (Leukemia*), Leukemia or leukemia cell line (Leukemia*), Acute lymphocytic leukemia - relapse (Leukemia), Acute lymphocytic leukemia - ALL1 sub class (Leukemia) |
Armstrong01_ALL_14 | Acute lymphocytic leukemia (Leukemia), B cells (Leukemia), Bone marrow (Leukemia), Lymphocytes (Leukemia), Acute leukemia (Leukemia*), Hematologic cancer (Leukemia*), Cancer (Leukemia*), Leukemia (Leukemia*), Monocytes (Leukemia*), Hematologic samples and cell lines (Leukemia*), Hematologic cancer and cell line (Leukemia*), Cancer and cell line (Leukemia*), Leukemia or leukemia cell line (Leukemia*), Acute lymphocytic leukemia - ALL1 sub class (Leukemia) |
Armstrong01_ALL_8 | Acute lymphocytic leukemia (Leukemia), B cells (Leukemia), Bone marrow (Leukemia), Lymphocytes (Leukemia), Acute leukemia (Leukemia*), Hematologic cancer (Leukemia*), Cancer (Leukemia*), Leukemia (Leukemia*), Monocytes (Leukemia*), Hematologic samples and cell lines (Leukemia*), Hematologic cancer and cell line (Leukemia*), Cancer and cell line (Leukemia*), Leukemia or leukemia cell line (Leukemia*), Acute lymphocytic leukemia - ALL1 sub class (Leukemia) |
Bhattacharjee01_AD-301t1-A237-8 * | Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Adenocarcinoma (Lung cancer), Lung cancer (Lung cancer*), Non small cell lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Non small cell lung cancer and cell line (Lung cancer*), Stage T1 (Lung cancer) |
Bhattacharjee01_COID-COID8t1-A345-6 | Cancer (Lung cancer*), Cancer and cell line (Lung cancer*), Lung tissue, cancer or cell line (Lung cancer*), Lung cancer (Lung cancer*), Lung cancer or cell line (Lung cancer*), Stage T1 (Lung cancer), Lung carcinoid (Lung cancer) |
Chen02_HCC_HBV_HK18 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*) |
Chen02_HCC_HBV_SF12 | Hepatocellular carcinoma (Liver cancer), Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Invasive liver tumor (Liver cancer) |
Chen02_Hep40_cells | Cancer and cell line (Liver cancer), Liver tissue, cancer or cell line (Liver cancer*), Cell line (Liver cancer), Liver cancer cell line (Liver cancer) |
Chen02_Liver_HBV_HK89 | Cancer and cell line (Liver cancer), Hepatitis infected liver (Liver cancer*), Liver tissue (Liver cancer*), Liver tissue, cancer or cell line (Liver cancer*), Non-tumor liver tissue (Liver cancer), Cell line (Liver cancer) |
Chen02_Met_Colon_Carcinoid_SF11 | Adenocarcinoma (Liver cancer), Cancer and cell line (Liver cancer), Cancer (Liver cancer), Colon cancer metastasis to liver (Liver cancer), Colon tissue, cancer or cell line (Liver cancer), Colon cancer (Liver cancer), Colon cancer or cell line (Liver cancer), Metastasis (Liver cancer) |
Chen02_SNU387_cells | Cancer and cell line (Liver cancer), Liver tissue, cancer or cell line (Liver cancer*), Cell line (Liver cancer), Liver cancer cell line (Liver cancer) |
Golub99_AML SH 5 | Acute leukemia (Leukemia*), Hematologic cancer (Leukemia*), Cancer (Leukemia*), Leukemia (Leukemia*), Monocytes (Leukemia*), Hematologic samples and cell lines (Leukemia*), Hematologic cancer and cell line (Leukemia*), Cancer and cell line (Leukemia*), Leukemia or leukemia cell line (Leukemia*), Acute myelogeous leukemia (Leukemia) |
Perou00_184Aa | Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*) |
Perou00_HMVEC | Breast cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*) |
Perou00_MCF7_NCI | Breast cancer cell line (Breast cancer), Epithelial cell line (Breast cancer), Female hormonal cancer cell line (Breast cancer), Cell line (Breast cancer), Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*) |
Perou00_MDA_MB_231_NCI | Cell line (Breast cancer), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Mesenchemal cell line (Breast cancer) |
Perou00_NB4_ATRA | Cell line (Breast cancer), Cancer and cell line (Breast cancer*) |
Ramaswamy01_Tumor__CNS_Glioblastoma_GlioB_4 | Cancer (Various tumors), Cancer and cell line (Various tumors), Cancer (Various tumors*), Cancer and cell line (Various tumors*), CNS tumor (Various tumors), Malignant glioblastoma (Various tumors), CNS tissue, cancer or cell line (Various tumors), CNS cancer or cell line (Various tumors) |
Rosenwald01_CLL_57 | Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Chronic lymphocytic leukemia (B lymphoma), Leukemia (B lymphoma), Leukemia or leukemia cell line (B lymphoma) |
Ross01_HB2 | Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Ross01_HME31 | Cell line (NCI60*), Cancer and cell line (NCI60*), Breast cancer cell line (NCI60), Female hormonal cancer cell line (NCI60), Breast cancer or cell line (NCI60), Breast tissue, cancer or cell line (NCI60), Female hormonal tissue, cancer or cell line (NCI60) |
Shipp02_DLBC38 | Hematologic samples and cell lines (B lymphoma), Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), Lymphoma (B lymphoma) |
Shipp02_DLBC4 | Hematologic samples and cell lines (B lymphoma), Lymphoma or lymphoma cell line (B lymphoma), Lymphocytes (B lymphoma*), Hematologic cancer and cell line (B lymphoma*), Cancer and cell line (B lymphoma*), B cells (B lymphoma*), Diffuse large B cell lymphoma tumor or cell line (B lymphoma), Hematologic cancer (B lymphoma*), Cancer (B lymphoma*), Diffuse large B cell lymphoma - DLBCL (B lymphoma), Lymphoma (B lymphoma) |
Sorlie01_BC201B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC210B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC404B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC406A_2ndTUMOR | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |
Sorlie01_BC503B_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Dead prognosis (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC610A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer) |
Sorlie01_BC704B_AF | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), After doxorubicin chemotherapy (Breast cancer), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 1 (Breast cancer) |
Sorlie01_BC713A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Grade 3 (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC805A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Grade 3 (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC807A_BE | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Wild type p53 tumor (Breast cancer), Grade 3 (Breast cancer) |
Sorlie01_BC_HBC2 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC_HBC3 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*), Estogen receptor (ER) positive breast cancer (Breast cancer), Dead prognosis (Breast cancer), Breast cancer - (prognostic) relapse (Breast cancer), Mutated p53 tumor (Breast cancer) |
Sorlie01_BC_HBC6 | Breast tissue, cancer or cell line (Breast cancer*), Breast cancer or cell line (Breast cancer*), Cancer and cell line (Breast cancer*), Female hormonal cancer or cell line (Breast cancer*), Female hormonal tissue, cancer or cell line (Breast cancer*), Adenocarcinoma (Breast cancer*), Breast cancer (Breast cancer*), Cancer (Breast cancer*), Breast tissue or cancer (Breast cancer*), Female hormonal cancer (Breast cancer*), Female hormonal tissue or cancer (Breast cancer*) |